These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38233673)

  • 21. Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy.
    Elliott P; Drachman BM; Gottlieb SS; Hoffman JE; Hummel SL; Lenihan DJ; Ebede B; Gundapaneni B; Li B; Sultan MB; Shah SJ
    Circ Heart Fail; 2022 Jan; 15(1):e008193. PubMed ID: 34923848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted Therapeutics for Transthyretin Amyloid Cardiomyopathy.
    Campbell CM; Baiyee CAMT; Almaani S; Bumma N; Sharma N; LoRusso S; Redder E; Bittengle J; Pfund K; Friemer M; Tong M; Kahwash R; Efebera Y; Parikh S; Vallakati A
    Am J Ther; 2023 Sep-Oct 01; 30(5):e447-e453. PubMed ID: 37713689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant.
    Lyng CS; Gude E; Hodt A; Knudsen EC
    Scand Cardiovasc J; 2023 Dec; 57(1):2174269. PubMed ID: 36734834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac Amyloidosis Due to Transthyretin Protein: A Review.
    Ruberg FL; Maurer MS
    JAMA; 2024 Mar; 331(9):778-791. PubMed ID: 38441582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and Rationale the SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study.
    Ruberg FL; Blaner WS; Chiuzan C; Connors LH; Einstein AJ; Fine D; Helmke S; Kurian D; Pandey S; Raiszadeh F; Rodriguez C; Sabogal N; Teruya S; Winburn M; Chung WK; Cohn E; Miller EJ; Kelly JW; Maurer MS
    J Am Heart Assoc; 2023 Apr; 12(8):e028534. PubMed ID: 37066788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
    Maurer MS; Schwartz JH; Gundapaneni B; Elliott PM; Merlini G; Waddington-Cruz M; Kristen AV; Grogan M; Witteles R; Damy T; Drachman BM; Shah SJ; Hanna M; Judge DP; Barsdorf AI; Huber P; Patterson TA; Riley S; Schumacher J; Stewart M; Sultan MB; Rapezzi C;
    N Engl J Med; 2018 Sep; 379(11):1007-1016. PubMed ID: 30145929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transthyretin amyloid cardiomyopathy.
    Garcia-Pavia P; Domínguez F; Gonzalez-Lopez E
    Med Clin (Barc); 2021 Feb; 156(3):126-134. PubMed ID: 33138983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of binding-site occupancy, transthyretin stabilisation and disease modification in patients with tafamidis-treated transthyretin amyloid cardiomyopathy.
    Tess DA; Maurer TS; Li Z; Bulawa C; Fleming J; Moody AT
    Amyloid; 2023 Jun; 30(2):208-219. PubMed ID: 36399070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging therapies in transthyretin amyloidosis - a new wave of hope after years of stagnancy?
    Müller ML; Butler J; Heidecker B
    Eur J Heart Fail; 2020 Jan; 22(1):39-53. PubMed ID: 31912620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of wild-type transthyretin amyloid cardiomyopathy in Japan: red-flag symptom clusters and diagnostic algorithm.
    Inomata T; Tahara N; Nakamura K; Endo J; Ueda M; Ishii T; Kitano Y; Koyama J
    ESC Heart Fail; 2021 Aug; 8(4):2647-2659. PubMed ID: 34137515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy.
    Park J; Egolum U; Parker S; Andrews E; Ombengi D; Ling H
    Ann Pharmacother; 2020 May; 54(5):470-477. PubMed ID: 31735059
    [No Abstract]   [Full Text] [Related]  

  • 33. Review of Transthyretin Silencers, Stabilizers, and Fibril Removal Agents in the Treatment of Transthyretin Cardiac Amyloid.
    Hough A; Wearden J; de Almeida K; Kaiser S
    Curr Cardiol Rep; 2020 Aug; 22(10):106. PubMed ID: 32770401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy review: Emerging treatment modalities in transthyretin cardiac amyloidosis.
    Plumadore E; Lombardo L; Cabral KP
    Am J Health Syst Pharm; 2022 Jan; 79(2):52-62. PubMed ID: 34491302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience.
    Siddiqi OK; Mints YY; Berk JL; Connors L; Doros G; Gopal DM; Kataria S; Lohrmann G; Pipilas AR; Ruberg FL
    Amyloid; 2022 Jun; 29(2):71-78. PubMed ID: 35083944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation.
    Tini G; Vianello PF; Gemelli C; Grandis M; Canepa M
    J Cardiovasc Transl Res; 2019 Dec; 12(6):514-516. PubMed ID: 30604309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy.
    Rozenbaum MH; Large S; Bhambri R; Stewart M; Young R; Doornewaard AV; Dasgupta N; Masri A; Nativi-Nicolau J
    J Comp Eff Res; 2021 Aug; 10(11):927-938. PubMed ID: 34142865
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice.
    Witteles RM; Bokhari S; Damy T; Elliott PM; Falk RH; Fine NM; Gospodinova M; Obici L; Rapezzi C; Garcia-Pavia P
    JACC Heart Fail; 2019 Aug; 7(8):709-716. PubMed ID: 31302046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with heart failure with preserved ejection fraction (HFpEF) in United States.
    Lau ATC; DiDomenico RJ; Kim K
    Int J Cardiol; 2024 Mar; 398():131598. PubMed ID: 37979789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid Cardiomyopathy.
    Bart NK; Thomas L; Korczyk D; Atherton JJ; Stewart GJ; Fatkin D
    Heart Lung Circ; 2020 Apr; 29(4):575-583. PubMed ID: 32001152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.